Drug Design and Delivery Webinar

May 20, 2021

Drug design and delivery

Theme: A modern Perspective of Drug design

Webinar on Drug design and delivery 2021 welcomes each one of you to attend a global Webinar in the field of Pharmacy which is held on May 20, 2021. The Webinar emphasizes the theme "A modern Perspective of Drug design”. Drug design and delivery Webinar provides an international dais for Scientists and Pharmaceutical professionals to exchange Ideas, knowledge and networking. Knowledge of the concepts of drug metabolism is useful in both the design of new drugs and the improvement of existing drugs. Thus it affects the living life in an effective way. This is the platform where you can exchange your ideas and learn novel concepts related to your field from the international speakers as well as the professionals participating in this symposium.

Novel Drug Delivery

Novel Drug delivery System (NDDS) developed in order to reduce drug degradation, drug adverse effect, and in order to maximize the drug bioavailability (amount of drug available at site targeted region).  Site specific drug delivery may be active or passive process. Novel Drug Delivery System is a fusion of advanced skills and advanced dosage forms which are far fitter than conventional dosage forms. Evolution of an existing drug molecule from a conventional form to a novel delivery system can importantly improve its presentation in terms of patient acquiescence, security and potency.  In the form of a Novel Drug Delivery System a live drug molecule can get a new life.

Drug Targeting and Design

Target drug delivery system is a marked form of drug delivery system. The therapeutic response of a drug based upon the interaction of drug molecules with cell on cell membrane interconnected biological events at receptor sites in concentration dependent manner. Targeted drug delivery entail for selective and functional localization of pharmacologically active moiety at pre recognized (preselected) target in therapeutic concentration, while moderate its entrance to non-target normal cellular linings, thus reduce toxic effects and increase therapeutic index. Targeting of drugs to marked cells and tissues of the body without their becoming a part of systemic circulation is a tremendous novel idea. If a drug can be distribute in a form such that it reaches the receptor sites in adequate concentration without interrupting in extraneous tissue cells.

Advanced Drug Delivery Systems

Advanced drug delivery systems (DDS) involves indubitable advantages for drug administration. Over the past three decades, new proposals have been recommended for the evolution of novel carriers for drug delivery. General concepts and emerging research in this field based on multidisciplinary proposals aimed at generate customized treatment for a broad range of highly universality diseases (e.g., cancer and diabetes). This review is made of two parts. The first part supply an overview on currently available drug delivery technologies counting a brief history on the development of these systems and some of the research strategies applied. The second part supply information about the most advanced drug delivery devices using stimuli-responsive polymers.

Drug repurposing to treat Viruses: COVID-19

Drug repurposing is a methodology for making more value from an existing drug by targeting diseases by focusing on infections other than that for which it was initially proposed, For instance, teicoplanin, oritavancin, dalbavancin and monensin are affirmed antibiotics that have been appeared to inhibit corona- and other viruses in the research facility. The researchers reviewed information on the discovery and development of wide-spectrum antiviral agents (BSAAs), which are drugs that target viruses from two or more different viral families. They condensed what they found for 120 drugs that had just been demonstrated to be ok for people use and made a database, which is uninhibitedly available Thirty-one of these were found by the researchers to be possible candidates for prophylaxis and treatment of the COVID-19 infections. The researchers also found that clinical investigations have recently begun of five possible drug candidates to treat the virus that causes COVID-19.

Glioma-Targeted Drug Delivery

Another dual targeting drug delivery system was combining trans-BBTB targeting with brain tumor cell targeting. For instance, a single targeting moiety (RGD) was utilized to target both BBTB and tumor cells. With the development of the tumor, tumor neovasculature has formed to support the growth of gliomas.

Advanced Polymeric Drug Delivery Systems

This technique was originally developed for separation applications; however, MIPs have recently been studied for biomedical applications, including drug delivery (120, 121). MIPs demonstrate great potential as advanced drug delivery systems owing to the affinity between the drug template and polymer pendant groups.

Anticancer Drug-Delivery Agents

Nanocarriers are used as targeting agents for cancer therapy comprising anticancer drugs, targeting moieties, and polymers. There are a variety of nanocarriers such as liposomes, dendrimers, micelles, carbon nanotubes, nanocapsules, nanospheres, and so forth.

Drug Delivery Systems Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027, The global “Drug Delivery system” Market is projected to reach USD 45.20 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period. Increasing prevalence of multiple chronic conditions (MCCs) worldwide is expected to be the leading factor driving the growth of this market, finds Fortune Business Insights™ in its report, titled “Drug Delivery Systems Market Size, Share and Industry Analysis, By Type (Inhalation, Transdermal, injectable and Others), By Device Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Regional Forecast, 2020-2027”.

MCCs refer to the existence of more than one chronic condition in an individual. According to a study published by the World Economic Forum (WEF), 33% of adults around the world suffer from a combination of MCCs such as cardiovascular disease with diabetes and depression or even cancer. Precision Drug Delivery Systems can play a crucial role in managing these conditions as they are able to administer drugs at the exact location of the disease. As incidence of chronic conditions rises, the demand for these systems is likely to spike in the coming years.

 Major Drug Delivery Systems Market Key players covered in the report include:

  • Pfizer Inc.(U.S)
  • West Pharmaceutical Services, Inc.(U.S)
  • Medtronic (Ireland)
  • Baxter International Inc. (S)
  • BD (Becton, Dickinson and Company)(U.S)
  • Nemera  (France)
  • Gerresheimer AG (Germany)
  • 3M (S)

Market Opportunity

 Coronavirus Pandemic to Create Multiple Opportunities in the Market

The drug delivery systems market growth is set to enter an animated period on account of the exponential spread of the COVID-19 infection. With the absence of a vaccine, healthcare professionals have been forced to rely on curative measures to alleviate the suffering of COVID-19 patients. In such dire circumstances, there is growing reliance on efficient drug delivery mechanisms to provide quick treatment for the disease. Moreover, the situation has generated several innovation opportunities for companies. For instance, in May 2020, UK-based senzer Drug Delivery Systems announced that it was working on creating inhalable targeted antivirals for COVID-19. Similar efforts are being made at the University of Texas at Austin where an innovative inhaled formulation of niclosamide is being developed to treat COVID-19 symptoms. Thus, the outbreak of the coronavirus pandemic has renewed the interest in drug delivery research and innovation.

Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

 The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global Drug Delivery Systems market and discusses how major companies are coping with this.

 The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Drug Delivery Systems Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

 Drug Delivery Systems Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, R and D activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analysis the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

 

Drug design and delivery 2021 helps to inform and attract new customers quickly and efficiently. The size and diversity of our advertising options, including banners, sponsored emails, article alerts or newsletters, provide clients with the very best customized marketing opportunities in science and medicine. We are one of the renowned events organizing platform with most of eminent speakers and business audience form all over the globe indexed. The advertising platform we provide you is the best chance of showcasing your products/services, and branding your company. If you are looking for a global exposure for your products and services, this is the right place for you. With over 5 million readers worldwide and nearly 3 million hits a month on our website, we have engaged audience of students, research scholars, scientists, doctors, professors, pharmacists and professionals from companies across the territories. If you sell research materials, products, medicinal instruments, or service like rehabilitation centres, here is your opportunity to advertise in the website that can connect you to leading experts and science specialists across the Globe. Advertisement banner must be provided in high resolution jpg or jpeg format by the advertising company and must not have copyright infringement. We can also support your events and conferences by providing you with high quality reprints of published articles that can add value to your event.

  • Novel Drug Delivery
  • Drug Targeting and Design
  • Advanced Drug Delivery Systems
  • Drug repurposing to treat Viruses: COVID-19
  • Glioma-Targeted Drug Delivery
  • Advanced Polymeric Drug Delivery Systems
  • Anticancer Drug-Delivery Agents

1 Renowned Speakers

Patrick Anquetil

CEO Portal Instruments
United States of America